Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

682 IndexSexual behaviorHIV infection risk, 411, 415, 417polydrug use and, 262women with addictive disorders,441Sexual dysfunction, alcohol-related, 89–90Sexual harassment/assault, 357, 360, 439,443, 445Skin problems, alcohol-related, 96Sleep disorders, alcohol-induced, 89Smoking. See TobaccoSocial anxiety disorder, alcohol use and,80Social Relationship Scale, 53Sociocultural contextabstinence movements, 25–26alcohol use patterns, 82–84attitudes toward alcohol use bywomen, 444–445, 448–449benefits of substance use, 16epidemic substance abuse, 20–21, 27–28historical evolution of substance abusetreatment, 23–27, 29–32historical evolution of substance use,17–23, 28–29patterns of substance use, 20–21pharmacodynamics and, 18–19significance of, 16Sports. See Athletes, drug testing forStages-of-change model, 282–283, 465–466, 489–490Steroids, 560Stimulus augmentation, 40Stressin neurobiology of addiction, 12workplace, 55Structured Clinical Interview for DSM-III-R, 48Substance Abuse Problem Checklist,53Substance use disorderassessment and diagnosis, 278clinical features, 222–223co-occurring pathological gambling,308–309impulse control disorders and, 304–305See also Comorbidity, psychiatric;specific substanceSuicidal behavior/ideation, adolescentsubstance use and, 566–567Sweat analysis, 65Symptom Checklist 90–Revised, 49TTelephone consultation, in dialecticalbehavior therapy, 632Temazepam, 229Testicular atrophy, 95Theophylline, 113Therapeutic relationshipin cognitive therapy, 483–485, 490in dialectical behavior therapy, 623–624, 630–631in family therapy, 535in group therapy, 508in psychodynamic psychotherapy, 463,464–465, 467–468, 469racial/ethnic context, 328substance abuse among highresponsibilityworkers and, 350–351in treating alcoholism, 97, 98Thiamin, 88, 92, 94Thin layer chromatography, 64, 65Thrombocytopenia, alcohol-induced, 94,95Thyroid dysfunction, alcohol-related, 95Tobacco, 21, 351acute intoxication, 112addictive potential, 107, 115adolescent use patterns, 560, 561AIDS infection and, 418–419alcohol abuse and, 79anti-smoking movement, 107–108assessment of use, 116–117benefits of quitting, 113–114business interests, 108, 109cocaine use and, 193–194dependence, 110–111drug interactions, 113